August 16, 2018
Dr. Nicholas F. Callahan brings a wealth of education to his new role as assistant professor of Oral and Maxillofacial Surgery (OMFS) at the University of Illinois at Chicago College of Dentistry.
He earned his BS in biochemistry from Trinity College, Hartford, CT; an MPH and DMD from the University of Pittsburgh; his MD and general surgery internship certificate from the State University of New York in Brooklyn; his certificate in OMFS from the Kings County Hospital Center in Brooklyn; and a Fellowship in head and neck oncology and microvascular surgery from the University of Maryland in Baltimore.
Previously, he has taught at Trinity College, Kings County Hospital Center, the University of Maryland, and the R.A. Cowley Shock Trauma Center in Baltimore.
Callahan is “involved in all aspects of the residency program training program, with a particular interest in the management of head and neck cancer patients and the reconstruction of traumatic defects,” he said. “I will also be involved in clinical and translational research. I also hope to be involved with mentoring of dental students who have an interest in OMFS.”
Maxillofacial trauma and head and neck oncology are two of Callahan’s interests.
“I hope to expand the treatment of head and neck cancer patients here at UIC,” he said. “Myself and Dr. Michael Markiewicz [assistant professor] will be able to work together, allowing us to begin reconstruction while we are still removing the tumor, which will lead to less time in the operating rooms for our patients.”
At the college, Callahan is pleased that he can provide state-of-the-science care to patients, “offering them the latest in technology such as robotic surgery and complex computer planning for oncologic and microvascular reconstruction,” he said. “We can use these techniques to provide complete reconstruction for these patients, replacing bones, soft tissue, nerves, and teeth.”
Callahan noted that, “UIC is already one of the leaders in the OMFS world and I hope that my addition will allow us to continue to grow, and to create more opportunities to expand our head and neck cancer and reconstruction program both clinically and academically.”